Spironolactone
Product Images NDC 68071-2968

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-2968). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 2968 3)

Pdp (68071 2968 3)
Label for Spironolactone 100mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 30 tablets. Each tablet is described as white, oval, scored, and debossed with "MP 303". The label includes the NDC 68071-2968-3 and states "Rx Only". Storage instructions specify controlled temperature of 68-77°F.*
FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
Chemical structure of spironolactone showing its steroidal nucleus with attached functional groups including a lactone ring and a thioacetyl side chain.*
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
A Kaplan-Meier survival curve comparing the probability of an event over time in months for two groups: Spironolactone (n=822) and placebo (n=841). The graph shows a higher survival probability for the placebo group with a statistically significant difference (log-rank p < 0.001).*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
A forest plot chart showing hazard ratios (HR) with 95% confidence intervals (CI) across multiple subgroups including age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACEI use, and beta blocker use. The chart compares the effect of spironolactone versus placebo, with HR values and confidence intervals displayed for each subgroup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.